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Background: Use of administrative claims from multiple sources for research purposes is challenged by the lack of
consistency in the structure of the underlying data and definition of data across claims data providers. This paper
evaluates the impact of applying a standardized revenue code-based logic for defining inpatient encounters across
two different claims databases.
Methods: We selected members who had complete enrollment in 2012 from the Truven MarketScan Commercial
Claims and Encounters (CCAE) and the Optum Clinformatics (Optum) databases. The overall prevalence of inpatient
conditions in the raw data was compared to that in the common data model (CDM) with the standardized visit
definition applied.
Results: In CCAE, 87.18% of claims from 2012 that were classified as part of inpatient visits in the raw data were
also classified as part of inpatient visits after the data were standardized to CDM, and this overlap was consistent
from 2006 to 2011. In contrast, Optum had 83.18% concordance in classification of 2012 claims from inpatient
encounters before and after standardization, but the consistency varied over time. The re-classification of inpatient
encounters substantially impacted the observed prevalence of medical conditions occurring in the inpatient setting
and the consistency in prevalence estimates between the databases. On average, before standardization, each
condition in Optum was 12% more prevalent than that same condition in CCAE; after standardization, the prevalence
of conditions had a mean difference of only 1% between databases. Amongst 7,039 conditions reviewed, the difference
in the prevalence of 67% of conditions in these two databases was reduced after standardization.
Conclusions: In an effort to improve consistency in research results across database one should review sources of
database heterogeneity, such as the way data holders process raw claims data. Our study showed that applying the
Observational Medical Outcomes Partnership (OMOP) CDM with a standardized approach for defining inpatient visits
during the extract, transfer, and load process can decrease the heterogeneity observed in disease prevalence estimates
across two different claims data sources.
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Managed care administrative claims databases are
widely used in many pharmacoepidemiology studies
[1]. The medical claims data are derived during the
reimbursement process, and are generated from two
standard forms: Health Insurance Claim Form (HCFA-
1500) and Universal Billing form (UB-92). Health care
services provided by a single practitioner or practi-
tioner groups are submitted for payments on the
HCFA-1500 form, while hospital inpatient and acute
care outpatient services are submitted for payments on
the UB-92 format. While a secondary use of the infor-
mation, these claims databases are of great benefit for
observational research as they provide information on
large, heterogeneous populations of insured patients
that are geographically dispersed at generally lower
costs than those would be gathered by prospective data
collection and randomized clinical trials [1,2].
One challenge that researchers face using adminis-
trative claims databases from multiple sources is the
lack of consistency in the structure of the underlying
data. Claims data are maintained and used for research
through various institutions, including government
agencies (e.g. Centers for Medicare and Medicaid
Services Research Data Assistance Center [CMS ResDAC]),
large payers with affiliated research arms (e.g. Health-
Core, Optum), or claims processors who aggregate and
license data (e.g. IMS, Truven). Each of these organiza-
tions may store claims data in different technical envi-
ronments (e.g. SAS, Microsoft SQL Server, Oracle) and
have developed their own internal data structures to
record the claims information. The design of the data
structure can influence how the specific data elements
within source claims from the HCFA-1500 and UB-92
forms are represented and organized. For example, in
the Truven claims database [3], medical claims are
partitioned into separate tables for inpatient and out-
patient services with the inpatient services claims be-
ing classified by the presence of a ‘room and board’
revenue code. In the Optum Clinformatics database
[4], all medical service claims are maintained in a sin-
gle data table which contains a field to indicate claims
associated with an inpatient confinement. In both
cases, the choice of data structure and definition of
inpatient classification could be considered reasonable
approaches in preparing the data for research pur-
poses. However, the assumptions that underlie the
source structure are rarely described in any detail
within published research on these databases. It is
unknown whether the inconsistency in inpatient defin-
ition when taken across data vendors can have a mater-
ial impact on research findings or negatively impact
the ability to conduct cross-database comparisons of
analysis results.Due to these variations in format and variable defin-
ition, different researchers might make different deci-
sions on how to process the data as part of analysis and
these decisions can affect the results [5]. Even a simple
choice of using primary diagnosis versus any diagnoses
of a condition within the same administrative claim
database can make a difference in the cohort being stud-
ied. For example, it has been found that the use of a pri-
mary diagnosis of pneumonia and influenza discharges
to estimate influenza-associated hospitalization will not
fully capture the influenza cohort [6]. Being able to cor-
rectly define health care utilizations (i.e. visit types) is
another example of an important decision that re-
searchers need to make. When using administrative
claim databases for observational studies, many re-
searchers use the type of visits as a proxy for severity of
disease and it is often believed among some practitioners
that inpatient diagnoses are more reliable than out-
patient diagnoses for some conditions. For example, the
Mini-Sentinel pilot project conducted literature reviews
on the accuracy of administrative claims diagnostic
codes and found that when defining seizures, convul-
sions, or epilepsy from electronic healthcare data, posi-
tive predictive value ranged on the visit types: >90% for
emergency room (ER) visits, 59.7-79.1% for inpatient,
and extremely low for outpatient [7]. Since the definition
of visit types can vary among different claim databases,
the lack of standardization can serve as an additional
source of systematic error in any analysis where the type
of visits is important to the study design.
Currently there are many data network efforts trying
to reduce the variations among different databases by
converting different observational healthcare databases
into a standardized format (i.e. common data model
[CDM]), such as Mini-Sentinel [8], the Observational
Medical Outcomes Partnership (OMOP) [9,10], EU-ADR
[11], the National Patient-Centered Clinical Research Net-
work (PCORnet) [12], or Health Maintenance Organization
(HMO) Research Network (HMORN) [13]. By converting
data into the same format, one objective of those efforts is
to reduce the systematic error caused by variations in
format among different databases. Standardization
should increase transparency and improve the ability
of networks to replicate study results across multiple
institutions. A common challenge experienced across
all of these efforts is that standardizing a data model
structure - and in some instances, the content through
standardized vocabulary - does not ensure standard
conventions for handling specific information (visit
types, reversals etc.) are consistently applied across
participating institutions. Since the administrative
claim databases in the U.S. are derived from standard
reimbursement information, we believe it is possible to
develop standard definitions when such databases are
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have different source representations.
This paper describes the development of a standard-
ized definition for an inpatient visit in administrative
claim databases using revenue codes. Since the data is
originally derived from standardized forms, converting it
into standard format may offer a great opportunity to
improve consistency of the underlying data used for
multi-database research. We believe revenue and place
of service codes should provide an avenue to such
standardization since they are primarily used for reim-
bursement purposes and always available in administra-
tive claim databases. We applied such a common definition
to two different claims databases (Truven MarketScan
Commercial Claims and Encounters [CCAE] and Optum
Clinformatics [Optum]) while converting the raw data
into a CDM and evaluated whether this transformation
and standardization improves consistency in analysis re-
sults between the two databases. While there is no gold
standard source of truth on a patient’s visit status, we
believe that applying a consistent approach to its defin-
ition can improve transparency and reproducibility in
observational research. Our main motivation for this
study was to assess the impact of applying a standard
visit definition to two claims databases on the preva-
lence of health service utilization and disease prevalence
observed during inpatient encounters.
Methods
Data sources
The CCAE and Optum databases were used in this
study. These databases were chosen for study because
they are two large claims databases with have similar
distributions in types of private insurance (e.g., preferred
provider organization [PPO], HMO), age, and gender.
The CCAE database primarily consists of privately in-
sured population and captures administrative claims
with patient-level de-identified data from inpatient and
outpatient visits and pharmacy claims of large employers
and multiple insurance plans as well as patient’s enroll-
ment information (e.g., demographics, period of enroll-
ment, plan type). The version of CCAE database used
for this analysis contained over 140.6 m lives with med-
ical and/or pharmacy coverage, with data from 1/1/2000
to 10/31/2013. Optum contained 37 m privately insured
lives with data from 10/01/2005 to 12/31/2012 and all
its lives have both medical and pharmacy coverage. The
two primary differences between Optum and CCAE are
that 1) CCAE aggregates data from multiple payers while
Optum is primarily representative of one large payer and
2) CCAE contains only privately-insured patients, while
Optum contains both privately-insured patients and
Medicare beneficiaries. To make the databases more
comparable, the Medicare patients in Optum wereremoved for this analysis. Nothing a priori would sug-
gest that these populations would differ radically in rates
of disease by age and gender strata. More detailed infor-
mation on the tables utilized in the study can be found
in Additional file 1.
Sample selection
To ensure the populations from two databases had simi-
lar demographic distributions, we only included mem-
bers who had 2012 full-year enrollment of commercial
based insurances with both medical and pharmacy
coverage. We also excluded members whose ages in
2012 were greater than 65 or members with unknown
gender. Medical claims of eligible members with service
dates within 2012 were used for our analysis. We also
applied the same criteria for selecting eligible popula-
tions in other years (2006–2011) and repeated those
analyses after-mentioned in each of these years.
Study measures
Definition of inpatient visits in raw data
While the source data for Optum and CCAE come from
the same forms (UB-92 and HCFA-1500) the data ven-
dors organize the results in different ways. Optum has
created inpatient confinements in a medical claims table
to capture inpatient episodes occurring in an acute care
hospitalization or skilled nursing facility setting. Any
Optum records with an associated confinement identi-
fier, an Optum derived field, were considered as part of
an inpatient visit unless they were identified as ER
claims by the place of service field (this was recom-
mended as an inpatient visit definition from Optum).
CCAE has defined inpatient admissions by grouping ser-
vice records meeting certain criteria (e.g. a room and
board claim must be present) into one table; all claim re-
cords, except ER claims, in this table were considered as
inpatient visits (ER claims in CCAE can be identified by
service category). The codes for defining ER claims in
raw data can be found as part of Additional file 2.
Definition of inpatient visits in CDM
The raw data was converted into the OMOP CDM Ver-
sion 4 format [10,14]. Detailed documentation for the
conversion of these databases into the CDM format can
be found on the OMOP website [9]. When transforming
the raw data into the OMOP CDM format, we applied a
standardized classification approach to define inpatient
visits through the extract, transform, and load (ETL)
processing. We first assigned a claim type for each med-
ical claim record: If a record contained any of the rev-
enue codes for inpatient visits [15], it was assigned as an
inpatient claim; else if a record contained a place of ser-
vice code, revenue code, procedure code, or service sub-
category code (CCAE only) for an ER claim, it was
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outpatient claim. Then for each patient, we collapsed re-
cords of inpatient claims together as long as the time be-
tween the service end date of one record and the service
start date of the next was less than or equal to one day
apart, and each consolidated record was considered as
one inpatient visit. If an ER or outpatient claim occurred
during an inpatient visit, it would have been consoli-
dated into the inpatient visit unless it was an ER claim
that occurred on the first day of the inpatient visit. The
codes for defining inpatient or ER claims in both Optum
and CCAE can be found in Additional file 2. Figure 1
provides an example of a claim from CCAE’s outpatient
services table and how it was re-categorized to an in-
patient visit.
Analysis
We estimated the prevalence of all inpatient condi-
tions to evaluate the impact of our standardized ap-
proach. Inpatient conditions were defined based on
diagnosis codes observed in the primary position or
any of the secondary positions within the medical
claims. Diagnosis codes in both databases were na-
tively coded in International Classification of Diseases,Figure 1 Truven MarketScan Commercial Claims and Encounters (CCA
inpatient or emergency room visit.Ninth Revision (ICD-9), and all ICD-9 codes were
consistently grouped into Systematized Nomenclature
of Medicine – Clinical Terms (SNOMED-CT) using
the ICD-9 – SNOMED mapping made available within
the OMOP vocabulary [16]. For each database, the
prevalence of each condition in inpatient visits in raw
data was compared to that defined in the CDM. We
also compared the prevalence of each inpatient condi-
tion in the Optum raw data and the CDM to that in
the CCAE raw data and the CDM, respectively. The
standardized difference (SD) was also used to compare
the differences of prevalences of the top ten SNOMED-
CT conditions [17]. We evaluated concordance be-
tween the raw and CDM through R2 correlation statistic.
We fit four linear regression models to the prevalence
estimates of all conditions: comparing the raw data
versus the CDM for both CCAE and OPTUM and
additionally comparing the prevalence between Optum
and CCAE for the CDM and RAW. Data preparation
and analysis were performed using SAS® version
9.3_M1, SAS Institute Inc. Spotfire® 5.5.0, TIBCO®
Software Inc. was used to generate visualizations and
display the y-intercept (a), slope (b), and R2 of the re-
gression (r2).E) reclassification of a single patient’s outpatient record to
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The analyses using the Optum and CCAE databases
were reviewed by the New England Institutional Review
Board (NEIRB) and determined to be exempt from
board IRB approval as this research project involved no
risk to the subjects and does not meet the definition of
human subject research (NEIRB#12-284 & NEIRB# 12–
286). We obtain these de-identified patient-level dataset
through a license agreement with each data holder.Results
Table 1 reports the demographic distribution of eligible
members in CCAE and Optum during the year of 2012.
CCAE has more than 3 times as many active members
in 2012 as Optum. The two databases are similar in
terms of age and gender. Our stratified analysis by age
and gender showed such demographic differences had
no impact on the findings in Figures 2, 3 and 4. The
demographic profile in CCAE for 2012 was similar to
the demographic profile for Optum during the same
period. The demographics in both databases were con-
sistent from 2006 through 2011.
We illustrate the reclassification of claims which were
classified as inpatient claims in raw data or the CDM for
each year from 2006 to 2012 in Figure 2. In 2012, among
claims that were classified as inpatient visits by the raw
data or the CDM, 87.18% were in the overlap and
12.82% were only in the CDM (i.e. defined as outpatient
claims in the raw data) for CCAE while for Optum those
numbers were 83.18% and 3.43% respectively. We also
found that CCAE followed the same inpatient classifica-
tion pattern exhibited in 2012 among years from 2006 to
2011, while Optum varied in this classification (notably
in 2008, 2009, and 2010 the percent of records classified
as inpatient only in the CDM were 11.77%, 19.12%, andTable 1 Demographics during 2012
Statistic CCAE Optum
Number of eligible members 28,747,530 7,924,173











SD = Standard deviation.14.75% respectively instead of around 3-4% as we see in
other years).
We then examined the impact of the visit classification
on the prevalence of diseases in an inpatient setting.
Table 2 shows the top ten selected SNOMED-CT condi-
tions, and the prevalence estimates in the raw data and
the CDM. In most situations, we found the standardized
difference of the prevalence of a specific condition be-
tween two databases was less in the CDM than in the
raw data. For example, we see the prevalence of the con-
cept of “Abdominal Pain” in CCAE goes up from 0.41%
in the raw data to 0.50% within the CDM and the preva-
lence in the Optum data goes down from 0.50% in the
raw data to 0.45% within the CDM, and the two data-
bases have more consistent prevalence estimates after
standardization to CDM. In total, amongst 7,039 condi-
tions reviewed, the difference in the prevalence of 67%
of conditions in these two databases was reduced after
standardization, while 23% of condition prevalence esti-
mates did not change after standardization. In the
remaining 10% of conditions, the prevalence between the
two databases became less consistent after standardization.
To review the changes for all the conditions reviewed,
please see the Additional file 3.
Figure 3 shows the comparison of prevalence of all
SNOMED-CT inpatient conditions in the raw data to
that in the CDM for both databases. Two lines within
the graphic are used to visualize the changes in preva-
lence of conditions in the databases: the dotted blue line
represents a 45-degree and the double black line is a fit-
ted line. If the raw and the CDM data were identical, the
prevalence of all inpatient conditions would fall on the
45-degree line. However, we observed the prevalence of
inpatient conditions in CCAE raw was lower than the
prevalence estimates from within the CDM (beta coeffi-
cient [b] = 0.94) while in Optum inpatient condition
prevalences were lower in the CDM than the raw data
(b = 1.06). The increase with CCAE was expected based
on our how standardization method was applied to that
database, but the directionality of the shift in prevalence
within of Optum was not prescribed by the algorithm.
This confirms the finding in Figure 2 that CCAE raw
data defined less inpatient claims while Optum raw data
defined more inpatient claims than the standardized ap-
proach. We performed the same analysis for the previ-
ous years, and the results confirmed the finding in 2012.
In Figure 4, we compared the prevalence of 2012 in-
patient conditions in Optum raw data and CDM to that
in CCAE raw data and the CDM, respectively. Before
standardization, we found that on average each condi-
tion in Optum was 12% more prevalent than that same
condition in CCAE (b = 1.12); after standardization,
there was only a 1% mean difference in the prevalence











































































Inpatient Visits That Both the CDM and Raw Data Agreed
Inpatient Visits Only Identified by CDM Data
Inpatient Visits Only Identified by Raw Data
Figure 2 Inpatient claims reclassification between raw and CDM data for 2006 through 2012.
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One of the challenges of using administrative claims
databases is database heterogeneity [18]. We typically
consider heterogeneity to arise from different studies
using data sampled from different source populations
using different data capture processes. One source of
heterogeneity that may be less commonly considered
among administrative claims databases may be the way
data holders process the raw data from the HCFA-1500
and UB-92 forms. Although there are many efforts
trying to minimize the impact of the variations among
claim databases from different data holders by applying
a common data model, bias can still be introduced
since different data holders may choose different rules
to convert their databases into a CDM. One specific
occasion involves defining inpatient visits. Here we
evaluated the application of a standard classification of
inpatient admissions to two administrative claims data-
bases when converting them into the OMOP CDM and
reviewed how that changed consistency between the
datasets.Our study showed that there are differences between
the databases in defining inpatient visits in the raw data.
As illustrated in Figure 3, CCAE seems to have less in-
patient admissions in the raw data, while Optum had
more. If we were to accept the raw data’s definitions for
inpatient, there is the potential for that to slightly skew
the data one way or another depending on the source
that you are using. We also found in Figure 2 that within
one raw data source you may have variation year to year
in how claims visits are being categorized.
However, when we converted the two databases into
the CDM and applied the standardized approach for de-
fining inpatient visits during ETL process, the two data-
bases became more comparable. As illustrated in
Figure 4, the prevalence of inpatient conditions became
similar between the two databases in the CDM. Our ap-
proach was revenue codes based and thus independent
of how each source handles the data derived from
HCFA-1500 and UB-92 forms. Each approach taken by
the data holders is not inherently incorrect, but the lack





Standard Difference Max (0.03845)
Standard Difference Min (0.00000)
Fitted Line
45-Degree
Figure 3 2012 prevalence of SNOMED-CT conditions in raw versus CDM in optum & CCAE.
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the analysis process when comparing results across data-
bases. For example, CCAE mentions in their documen-
tation that a small percentage of inpatient services fall
into their outpatient services table when no charges are
found, just a choice made for their processing however
this could be inconsistent with other data holders [19].
Therefore by leveraging the process of the ETL we can
create consistency with the definition of inpatient visits
across multiple claims datasets. Our ETL conversions of
the raw data have applied a consistent algorithm based
on common elements in each source database. We did
not evaluate the impact of alternative algorithms that
could have been considered. Further research would be
required to determine if a specific algorithm had better
operating characteristics than alternatives.
This study demonstrates the impact of standardization
on encounter classification and disease prevalence. It is
important to reinforce that the motivation for this work
was to improve consistency in research results across
databases by applying a common logical approach and
set of assumptions between sources. One limitation of
this analysis is the lack of available reference standard to
compare the prevalence estimates. The two populations
are different and therefore we do not know the extent to
which we could expect inconsistency. We have made thepopulations comparable through stratifications by age,
gender, and year, but it may be underlying disease and
health service utilization patterns account for differ-
ences. For these reasons, it is important to focus on the
relative comparison from the raw data to CDM-
transformed data, rather than the absolute prevalence
when evaluating the impact of applying a consistent al-
gorithm across sources. In addition, we were not able to
conduct source record verification to assess the validity
of the assumptions or to gauge whether one data
source’s original data structure is more or less reliable
than another in their ability to properly classify inpatient
encounters. It would be desirable to develop a common
approach that can be demonstrated to improve the reli-
ability of the information, but even in the absence of this
evidence, we believe establishing a common approach
that can be applied uniformly across all databases has
tremendous value.
This analysis provides a descriptive characterization of
the impact of standardization on the prevalence of impa-
tient visits and associated diseases. We did not provide
formal statistical test or compute measures for inter-
rater agreement, but instead relied on the distribution of
prevalence estimates and regression coefficients as the
means of illustrating the variability observed between












Standard Difference Max (0.03905)
Standard Difference Min (0.00000)
Fitted Line
45-Degree
Figure 4 2012 prevalence of SNOMED-CT conditions for CCAE versus optum in the raw & CDM datasets.
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those approaches could be applied across other data-
bases to further assess the generalizability of these find-
ings. Also, further work should be considered to assess
how standardization may impact length-of-stay and cost
summarization commonly used in health economic
analyses.
Standardizing definitions for visits is just one example of
an opportunity for improving consistency in observationalTable 2 Top 10 conditions of SNOMED-CT inpatient condition
Raw data
SNOMED-CT concept CCAE PR (%) Optum PR (%)
Essential hypertension 0.84 0.90
Single live birth 0.80 1.02
Mother delivered 0.72 0.82
FTND 0.58 0.64
Chest pain 0.44 0.50





CCAE = Truven MarketScan Commercial Claims and Encounters; Optum = Optum Cli
Common Data Model; FTND = Full term normal delivery; GERD = Gastro-esophageal
SD = Standardized Difference.research. The use of common data models in efforts
such as OHDSI, Mini-Sentinel, and PCORNet present
opportunities to establish shared conventions that go
beyond the basic data structure and content to impart
consistent interpretation of each data elements within
a source. Work to standardize analytical methods, as
has been done by OMOP and Cancer Intervention and
Surveillance Modeling Network (CISNET), is another
important step in this direction. The promise ofs in the raw versus the CDM data format
CDM data
SD CCAE PR (%) Optum PR (%) SD
0.006 0.87 0.84 0.002
0.024 0.80 0.99 0.020
0.011 0.72 0.79 0.008
0.007 0.60 0.62 0.003
0.008 0.51 0.46 0.007
0.015 0.50 0.45 0.007
0.001 0.40 0.36 0.007
0.005 0.34 0.28 0.011
0.004 0.34 0.32 0.003
0.011 0.31 0.29 0.004
nformatics; CDM = Observational Medical Outcomes Partnership (OMOP)
reflux disease; T2DM = Type 2 diabetes mellitus; PR = Prevalence;
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management through analysis execution and results
interpretation, should offer the ability to simultaneously
improve the efficiency, reliability, and reproducibility of
research activities.
When it comes to cross-database research, we support
the adage that it is better to be consistently wrong than
inconsistently right. That is, a primary challenge to re-
search across networks of disparate databases is man-
aging the various sources of error that can exist within
each source and determining how to reconcile those er-
rors when combining results across sources. Establishing
common standards and assumptions for data process
will reduce the variance in systematic error across the
network, even if some error based on the common
standard persists. To support the community in applying
consistent assumptions, we have made the ETL pro-
cesses we developed publically available [20,21], however
this code would still need to be configured to work
within each data network and may not be directly ap-
plicable to other structures used to store claims data.
Conclusions
Observational data networks are becoming an increas-
ingly important mechanism for real-world evidence gen-
eration, and the success of the networks will largely be
determined by their ability to generate consistent ana-
lysis results across each participating data source within
the network. Many observational data networks have
adopted a common data model as a tool to promote
greater consistency across the participants. The ETL
process of the source data into the CDM provides an ex-
plicit opportunity to impose common standards across
the data networks. Our study showed that applying the
OMOP CDM with a standardized approach for defining
inpatient visits during the ETL process can decrease the
heterogeneity observed in disease prevalence estimates
across two different claims data sources. For 90% of con-
ditions, standardization improved or maintained the
consistency of prevalence estimates, with an average
prevalence difference between the two databases nar-
rowing from 12% to 1% after standardization. It is im-
portant to note that for 10% of conditions, the
prevalence estimates after standardization were less con-
sistent; this finding underscores the need for the re-
search community to gain a complete understanding
and provide full transparency to all data transformation
activities that occur from the source through analyses, as
these manipulations can materially impact study results.
Defining visits is only one of the many conventions that
are needed to enforce consistency across a data network;
further community efforts are required to establish con-
sistent approaches for data quality assessment for other
data domains. The application of these commonstandards across databases is a necessary, but not suffi-
cient, step to improving the consistency, transparency,
and reliability of observational research.
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